期刊文献+

CA125、CA199联合超声检查在卵巢恶性肿瘤诊断中的价值 被引量:4

Value of Combined Measurement of CA125, CA199 and Ultrasonography in the Diagnosis of Ovarian Malignant Tumor
下载PDF
导出
摘要 [目的]探讨血清CA125、CA199联合超声检查在卵巢恶性肿瘤诊断中的价值.[方法]对2005年1月至2009年12月在本院住院的103例卵巢肿瘤患者进行血清CA125、CA199检测及超声检查,并分别以血清CA125〉35 u/mL、CA125〉100 u/mL;CA199〉37 u/mL、CA199〉70 u/mL;阻力指数RI〈0.5、RI〈0.6作为阳性结果,比较各种指标对卵巢恶性肿瘤预测的敏感性、特异性、阳性预测值和阴性值.[结果]卵巢恶性肿瘤患者血清CA125、CA199水平明显高于良性肿瘤组.多普勒血流显像恶性肿瘤组RI显著低于良性肿瘤组,且两组相比差异有显著性(P〈0.05), 超声联合血清CA125、CA199检查的敏感性可提高到90.9%,阴性预测值为90.1%,阳性预测值为96.1%,特异性为95.8%,与单独使用时比较均有提高.[结论]血清CA125 CA199联合多普勒超声血流显像可明显提高卵巢恶性肿瘤诊断的敏感性和特异性. [Objective]To explore the value of combined measurement of serum CA125, CA199 and ultra- sonography for the diagnosis of ovarian malignant tumor. [Methods]A total of 103 inpatients with ovarian tumor in our hospital from Jan. 2005 to Dec. 2009 were enrolled in this study. Serum CA125 and CA199 were measured. Ultrasonograpby was performed. The negative results were CA125 〉35u/ml, CA125 〉100u/ml, CA199 〉37u/ml, CA199 〉70u/ml, RI〈0. 5 and RI〈0.6, respectively. The sensitivity, specificity, positive and negative predictive values of all indexes for the prediction of ovarian malignant tumor were compared. [Results] The levels of serum CA125 and CA199 in ovarian malignant tumor group were obviously higher than those in ovarian benign tumor group. Resistance index of Doppler flow imaging in ovarian malignant tumor group was obviously lower than that in ovarian benign tumor group, and there was significant difference between two groups( P 〈0.05). The sensitivity of ultrasonography combined with serum CA125 and CA199 measurement increased up to 90.9%. Its negative and negative predictive value was 90.1% and 96.1%, respectively, and its specificity was 95.8%. Compared with simple measurement, the indexes of combined measurement were increased. [Conclusion] Combined measurement of CA125 ,CA199 and Doppler flow imaging can obviously improve the diagnostic sensitivity and specificity of ovarian malignant tumor.
作者 王俐英
出处 《医学临床研究》 CAS 2011年第3期475-476,482,共3页 Journal of Clinical Research
关键词 卵巢肿瘤/诊断 卵巢肿瘤/超声检查 抗原 肿瘤相关 ovarian neoplasms/DI ovarian neoplasms/US antigens,tumor-associated
  • 相关文献

参考文献7

二级参考文献20

  • 1张荣富,丁杰锋,赵文,刘琦.血清CA125、TSGF联检对卵巢癌诊断的临床价值[J].放射免疫学杂志,2006,19(4):315-316. 被引量:4
  • 2Jobling T,Mamers P,Healy DL,et al.A prospective study of inhibin in granulose cell tumors of the ovary[J].Gynecol Oncol,1994,55:285-289.
  • 3Mario L,Jeff B.Preoperative CA125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinoma[J].Gynecol Oncol,2002,84(5):413-415.
  • 4McGuire WP.CA125 and early ovarian cancer:does this help the clinican or further muddy the water[J] J Clin Oncol,2005,23(25):5862-5864.
  • 5Engelen MJ,de Bruijn HW,Hollema H,et al.Serum CA125,carcinoembryonic antigen,and CA199 as tumor markers in border-line ovarian tumors[J].Gynecol Oncol,2000,78(1):16-20.
  • 6Fioretti P,Gadducci A,Ferdeghini M,et al.The concomitant determination of different serum tumor markers in epithelial ovarian carcinoma.Relevance for monitoring the response to chemotherapy and follow up of patients[J].Gynecol Oncol,1992,44:155-157.
  • 7Boggess JF,Soules MR,Coff BA,et al.Serum inhibin and disease status in women with ovarian GCT[J].Gynecologic Oncol,1997,64:64-69.
  • 8Yokoyama Y,Higuchi T,Mizunuma H.The potential and problems of screening for ovarian cancer[J].Eur J Gynecol Oncol,2005,26(3):241-243.
  • 9Fishman DA,Cohen L,Blank SV,et al.The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer[J].Am J Obstet Gynecol,2005,192(4):1214-1222.
  • 10Healy DL,Burger HG,Mamers PRN,et al.Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors[J].Nengl J Med,1993,329:1539-1542.

共引文献11

同被引文献25

  • 1Husseinzadeh N. Status of tumor markers in epithelial ovarian cancer has there been any progress? Gynecol Oncol,2011,120 ( 1 ) : 152-157.
  • 2Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol, 2009,112( 1 ) - 40-46.
  • 3Kobel M,Kalloger SE, Boyd N, et al. Ovarian carcinoma subtypesare different diseases: implications for biomarker studies. PLOS Meal,2008,5(12) :1749-1759.
  • 4JemaI A, Siegel R, Xu Jiaquan, et al. Cancer Statistics,2010. CA Cancer J Clin ,2010,60(5) :277-300.
  • 5梁美蓉,曾四元.王素兰,等.人附睾蛋白4联合CA125检测在卵巢良恶性肿瘤诊断中的应用价值[J].中华临床医师杂志:电子版,2013,7(20);9148-9152.
  • 6Yoshikawa H, Jimbo H, Okada S,et al. Prevalence of endometriosis in ovarian cancer [ J]. Gynecol Obstet Invest, 2000,50 ( 12 ) : 11 - 17.
  • 7Garrett LA, GrowdonWB, Goodman A, et al. Endometriosis - associat- ed ovarian malignancy: a retrospective analysis of presentation, treat- ment, and outcome[J]. J Reprod Med, 2013,58( 11 -12) :469 -476.
  • 8Pearce CL, Templeman C, Rossing MA, et al. Association between en- dometriosis and risk of histological subtypes of ovarian cancel - : apooled analysis of case - control studies[ J]. Lancet Oncol, 2012,13 (4) :385 - 394.
  • 9董丽,昌晓红,叶雪,朱丽荣,赵旸,田莉,程洪艳,李小平,张虹,廖秦平,付天云,成夜霞,崔恒.血清人附睾分泌蛋白4和CA125水平检测在卵巢恶性肿瘤中的诊断价值[J].中华妇产科杂志,2008,43(12):931-936. 被引量:98
  • 10周绍明,马赟,龚颖平,李青春,崔毅,李博,吴湘,唐双玲.血清CA125检测结合CT对卵巢肿瘤的诊断价值[J].医学临床研究,2009,26(12):2257-2258. 被引量:1

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部